According to the drug's prescribing information, these potential risks are: An allergic reaction (hypersensitivity) Severe low blood sugar in people with type 2 diabetes, especially those taking insulin or sulfonylureas Complications related to diabetic retinopathy in those with type 2 diabetes Acute pancreatitis or gallbladder disease Acute kidney injury Increases in heart rate Suicidal ideation or behavior Lastly, Wegovy may increase the risk of certain thyroid tumors but this has only been observed in rodent studies
This rapid expansion suggests that the global adoption of GLP-1 drugs shows no signs of slowing down, and this is truly a blockbuster hit
If you are pregnant, nursing or taking any medications, consult your doctor before use
5C), indicating PYYs partial role as a PPRE activator
Treatment begins at the lowest dose and is gradually increased under provider guidance to ensure safety, minimize side effects, and achieve optimal results